EE9400182A - Peptide compounds, their use, method of preparation and pharmaceutical composition - Google Patents

Peptide compounds, their use, method of preparation and pharmaceutical composition

Info

Publication number
EE9400182A
EE9400182A EE9400182A EE9400182A EE9400182A EE 9400182 A EE9400182 A EE 9400182A EE 9400182 A EE9400182 A EE 9400182A EE 9400182 A EE9400182 A EE 9400182A EE 9400182 A EE9400182 A EE 9400182A
Authority
EE
Estonia
Prior art keywords
preparation
pharmaceutical composition
peptide compounds
peptide
compounds
Prior art date
Application number
EE9400182A
Other languages
Estonian (et)
Inventor
Undheim Kjell
Solbakken Magne
Lene Falck-Pedersen Mette
Agner Erik
Original Assignee
Hafslund Nycomed As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hafslund Nycomed As filed Critical Hafslund Nycomed As
Publication of EE9400182A publication Critical patent/EE9400182A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/067Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EE9400182A 1992-06-02 1994-11-16 Peptide compounds, their use, method of preparation and pharmaceutical composition EE9400182A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929211677A GB9211677D0 (en) 1992-06-02 1992-06-02 Peptide compounds

Publications (1)

Publication Number Publication Date
EE9400182A true EE9400182A (en) 1996-02-15

Family

ID=10716410

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400182A EE9400182A (en) 1992-06-02 1994-11-16 Peptide compounds, their use, method of preparation and pharmaceutical composition

Country Status (11)

Country Link
EP (1) EP0647237A1 (en)
JP (1) JPH08501065A (en)
CN (1) CN1085911A (en)
AU (1) AU4340293A (en)
EE (1) EE9400182A (en)
GB (1) GB9211677D0 (en)
LT (1) LT3613B (en)
LV (1) LV10286B (en)
NO (1) NO944668D0 (en)
WO (1) WO1993024522A1 (en)
ZA (1) ZA933867B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL104323A0 (en) * 1992-01-10 1993-05-13 Smithkline Beecham Corp Hemoregulatory peptides
GB9324691D0 (en) * 1993-12-01 1994-01-19 Hafslund Nycomed As Peptide compounds
GB9425730D0 (en) * 1994-12-20 1995-02-22 Nycomed Pharma As Compounds
KR102613337B1 (en) * 2015-09-17 2023-12-14 가부시키가이샤 아데카 Non-aqueous electrolyte and non-aqueous electrolyte secondary battery

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058512A (en) * 1975-04-28 1977-11-15 Ab Kabi Synthetic peptides having growth promoting activity
ZA838780B (en) 1982-11-26 1985-01-30 Nyegaard & Co As Peptide compounds
GB8626539D0 (en) * 1986-11-06 1986-12-10 Nycomed As Peptide compounds
GB8821785D0 (en) 1988-09-16 1988-10-19 Nycomed As Peptide compounds
ZW11290A1 (en) * 1989-07-14 1990-10-31 Smithkline Beecham Corp Hemoregulatory peptides

Also Published As

Publication number Publication date
WO1993024522A1 (en) 1993-12-09
LT3613B (en) 1995-12-27
CN1085911A (en) 1994-04-27
JPH08501065A (en) 1996-02-06
NO944668L (en) 1994-12-02
ZA933867B (en) 1994-06-14
LV10286B (en) 1995-04-20
AU4340293A (en) 1993-12-30
LTIP606A (en) 1995-01-31
GB9211677D0 (en) 1992-07-15
NO944668D0 (en) 1994-12-02
EP0647237A1 (en) 1995-04-12
LV10286A (en) 1994-10-20

Similar Documents

Publication Publication Date Title
EE03177B1 (en) Heterobicyclic compounds, methods for their preparation and pharmaceutical compositions containing said compounds
BR1100824A (en) Pharmaceutical composition and composition
EE9700145A (en) Cycloalkanepyridines, their method of preparation, their use in the manufacture of medicinal products and medicinal products containing these compounds
EE9500064A (en) Substituted 1H-imidazoles, methods for their preparation, and pharmaceutical compositions
EE9700061A (en) Pharmaceutical aerosol formulation and method of preparation
BR9602933A (en) Compound processes for preparation of compost and pharmaceutical composition and compost
IT1235532B (en) CARBOXYMIDE COMPOUNDS, PROCEDURES FOR THE PREPARATION OF THE SAME AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
FI943571A0 (en) 1-Benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one derivatives, their preparation and pharmaceutical compositions containing them
EE9800234A (en) Method of treatment and pharmaceutical composition
EE04681B1 (en) 3,6-Half-Ketals of the 9a-Azalides, Method of Preparation and Pharmaceutical Composition
FI951789A (en) Novel taxane derivatives, their preparation and pharmaceutical compositions containing them
FI942932A (en) Pharmaceutical composition and method for its preparation
IT8922164A0 (en) PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR ITS PREPARATION
FI961938A0 (en) Novel taxoids, their preparation and pharmaceutical preparations containing them
FI960316A (en) Oxathiolanes, process for their preparation and pharmaceutical compositions containing them
FI955123A (en) Cholestyramine-containing composition and method for its preparation
EE9400182A (en) Peptide compounds, their use, method of preparation and pharmaceutical composition
NO305750B1 (en) Substituted benzenesulfonylureas and their use in the preparation of pharmaceutical preparations and pharmaceutical preparations containing the compounds
BR9610851A (en) Compound compound preparation process medicine pharmaceutical composition and use of the compound
EE03101B1 (en) Peptide compounds, their use, method of preparation and pharmaceutical composition
FI960688A (en) Substituted benzenesulphonylureas and thioureas, process for their preparation and use of pharmaceutical preparations based on these compounds and medicinal products containing them
EE9500029A (en) Pharmaceutical spray composition and method for its preparation
FI952859A0 (en) Antacid composition and method of preparation
FI934387A0 (en) 3-SUBSTITUTES 2-OXI-INDOL-1-CARBOXIAMIDE PHARMACEUTICAL COMPOSITION
FI940717A (en) Purified forms of streptogramins, their preparation and pharmaceutical preparations containing them